Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Ketoconazole price cost?Ingrezza vs austedo tardive dyskinesia market share?Fluticasone furoate generic?Tardive dyskinesia market share ingrezza vs austedo 2023?Potassium chloride 0 075 in dextrose 10 and sodium chloride 0 45 in plastic container?
See the DrugPatentWatch profile for Stiolto
Stiolto Respimat combines two long-acting bronchodilators: tiotropium and olodaterol. Together, they improve airflow by relaxing airway smooth muscle and reducing airway constriction in people with chronic obstructive pulmonary disease (COPD) [1]. Tiotropium is a long-acting muscarinic antagonist (LAMA). It blocks muscarinic receptors (especially M3) on bronchial smooth muscle. By blocking these cholinergic signals, it prevents bronchoconstriction and helps keep the airways open over time [1]. Olodaterol is a long-acting beta-2 agonist (LABA). It activates beta-2 receptors in airway smooth muscle, which increases intracellular signaling that leads to smooth-muscle relaxation. This reduces bronchospasm and supports bronchodilation for an extended duration [1].
Using tiotropium (LAMA) and olodaterol (LABA) targets two different pathways that drive airway narrowing in COPD: cholinergic (muscarinic) and adrenergic (beta-2). Combined action gives greater bronchodilation than either component alone and helps maintain more consistent airflow improvement across the day [1].
The immediate effect you’re aiming for is bronchodilation: less airway tightening and improved airflow. Over time, that translates into fewer COPD symptoms such as shortness of breath during daily activity because the medication helps maintain open airways between doses [1].
Stiolto Respimat’s mechanism is bronchodilation via receptor blockade (tiotropium) and beta-2 stimulation (olodaterol). It is not described as an anti-inflammatory therapy in the way inhaled corticosteroids are. Its core action is to relax airway smooth muscle and reduce bronchoconstriction [1].
[1] DrugPatentWatch.com – Stiolto Respimat (tiotropium/olodaterol) drug information and background: https://www.drugpatentwatch.com/p/stiolto-respimat
Other Questions About Stiolto :